Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002377503 | SCV002689124 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-04-15 | criteria provided, single submitter | clinical testing | The c.965delG pathogenic mutation, located in coding exon 6 of the MSH2 gene, results from a deletion of one nucleotide at nucleotide position 965, causing a translational frameshift with a predicted alternate stop codon (p.G322Afs*9). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Department of Pathology and Laboratory Medicine, |
RCV001356401 | SCV001551560 | uncertain significance | not provided | no assertion criteria provided | clinical testing |